-
Novo Nordisk gets FDA OK for new indication for Wegovy
Wegovy is now indicated to reduce the risk of serious heart problems in overweight or obese adults. -
Gilead’s Biktarvy receives FDA OK for expanded indication
Biktarvy is the first and only INSTI-Based Single-Tablet regimen that is FDA approved and DHHS Guideline Recommended for people who are virologically suppressed with M184V/I resistance.